0001179110-20-007793.txt : 20200626 0001179110-20-007793.hdr.sgml : 20200626 20200626161031 ACCESSION NUMBER: 0001179110-20-007793 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200624 FILED AS OF DATE: 20200626 DATE AS OF CHANGE: 20200626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rowland Charles A Jr CENTRAL INDEX KEY: 0001383292 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37359 FILM NUMBER: 20994247 MAIL ADDRESS: STREET 1: 3338 LANCASHIRE RD CITY: FURLONG STATE: PA ZIP: 18925 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Blueprint Medicines Corp CENTRAL INDEX KEY: 0001597264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-374-7580 MAIL ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2020-06-24 0 0001597264 Blueprint Medicines Corp BPMC 0001383292 Rowland Charles A Jr C/O BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREET CAMBRIDGE MA 02139 1 0 0 0 Common Stock 2020-06-24 4 A 0 2250 0 A 3562 D Stock Option (Right to Buy) 76.24 2020-06-24 4 A 0 4500 0 A 2030-06-24 Common Stock 4500 4500 D The reported transaction involved the Reporting Person's receipt of a grant of restricted stock units. The restricted stock units vest with respect to 100% of the shares underlying the restricted stock units on the earlier of (i) the next annual meeting of the Issuer's stockholders and (ii) June 24, 2021. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. This option vests with respect to 100% of the shares underlying the option on the earlier of (i) the next annual meeting of the Issuer's stockholders and (ii) June 24, 2021. /s/ Christopher Frankenfield, Attorney-in-Fact 2020-06-26